17-40390141-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001067.4(TOP2A):c.4291G>A(p.Gly1431Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,612,428 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001067.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 152006Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000324 AC: 8AN: 246922Hom.: 0 AF XY: 0.0000224 AC XY: 3AN XY: 134042
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1460422Hom.: 0 Cov.: 31 AF XY: 0.00000964 AC XY: 7AN XY: 726500
GnomAD4 genome AF: 0.0000461 AC: 7AN: 152006Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74230
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.4291G>A (p.G1431S) alteration is located in exon 34 (coding exon 34) of the TOP2A gene. This alteration results from a G to A substitution at nucleotide position 4291, causing the glycine (G) at amino acid position 1431 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at